| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
CUTTING EDGE |
,
,
,,
Departments of
*
Medicine and
Microbiology and Immunology, University of Western Ontario, and Divisions of
Rheumatology and
Nephrology, London Health Sciences Center, London, Ontario, Canada; and
¶ Epimmune, Inc., and
|| La Jolla Institute for Allergy and Immunology, San Diego, CA 92121
Rheumatoid arthritis (RA) is genetically associated with MHC class II molecules that contain the shared epitope. These MHC molecules may participate in disease pathogenesis by selectively binding arthritogenic peptides for presentation to autoreactive CD4+ T cells. The nature of the arthritogenic Ag is not known, but recent work has identified posttranslationally modified proteins containing citrulline (deiminated arginine) as specific targets of the IgG Ab response in RA patients. To understand how citrulline might evoke an autoimmune reaction, we have studied T cell responses to citrulline-containing peptides in HLA-DRB1*0401 transgenic (DR4-IE tg) mice. In this study, we demonstrate that the conversion of arginine to citrulline at the peptide side-chain position interacting with the shared epitope significantly increases peptide-MHC affinity and leads to the activation CD4+ T cells in DR4-IE tg mice. These results reveal how DRB1 alleles with the shared epitope could initiate an autoimmune response to citrullinated self-Ags in RA patients.
This article has been cited by other articles:
|
|
 |
|
  A. Beltrami, M. Rossmann, M. T. Fiorillo, F. Paladini, R. Sorrentino, W. Saenger, P. Kumar, A. Ziegler, and B. Uchanska-Ziegler Citrullination-dependent Differential Presentation of a Self-peptide by HLA-B27 Subtypes J. Biol. Chem., October 3, 2008; 283(40): 27189 - 27199. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W H Bos, J Ursum, N de Vries, G M Bartelds, G J Wolbink, M T Nurmohamed, I E van der Horst-Bruinsma, R J van de Stadt, J B A Crusius, P P Tak, et al. The role of the shared epitope in arthralgia with anti-cyclic citrullinated peptide antibodies (anti-CCP), and its effect on anti-CCP levels Ann Rheum Dis, September 1, 2008; 67(9): 1347 - 1350. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Barton, W. Thomson, X. Ke, S. Eyre, A. Hinks, J. Bowes, L. Gibbons, D. Plant, Wellcome Trust Case Control Consortium, A. G. Wilson, et al. Re-evaluation of putative rheumatoid arthritis susceptibility genes in the post-genome wide association study era and hypothesis of a key pathway underlying susceptibility Hum. Mol. Genet., August 1, 2008; 17(15): 2274 - 2279. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D Mewar, I Marinou, A L Coote, D J Moore, M Akil, D Smillie, M C Dickson, M H Binks, D S Montgomery, and A G Wilson Association between radiographic severity of rheumatoid arthritis and shared epitope alleles: differing mechanisms of susceptibility and protection Ann Rheum Dis, July 1, 2008; 67(7): 980 - 983. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Tilleman, K. Van Steendam, T. Cantaert, F. De Keyser, D. Elewaut, and D. Deforce Synovial detection and autoantibody reactivity of processed citrullinated isoforms of vimentin in inflammatory arthritides Rheumatology, May 1, 2008; 47(5): 597 - 604. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Hill, D. A. Bell, W. Brintnell, D. Yue, B. Wehrli, A. M. Jevnikar, D. M. Lee, W. Hueber, W. H. Robinson, and E. Cairns Arthritis induced by posttranslationally modified (citrullinated) fibrinogen in DR4-IE transgenic mice J. Exp. Med., April 14, 2008; 205(4): 967 - 979. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L Michou, V H Teixeira, C Pierlot, S Lasbleiz, T Bardin, P Dieude, B Prum, F Cornelis, and E Petit-Teixeira Associations between genetic factors, tobacco smoking and autoantibodies in familial and sporadic rheumatoid arthritis Ann Rheum Dis, April 1, 2008; 67(4): 466 - 470. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T.B. Niewold, M.J. Harrison, and S.A. Paget Anti-CCP antibody testing as a diagnostic and prognostic tool in rheumatoid arthritis QJM, April 1, 2007; 100(4): 193 - 201. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D Ligeiro, J E Fonseca, O Abade, I Abreu, M Cruz, P Nero, J Cavaleiro, J Teles, H Trindade, J M Caetano, et al. Influence of human leucocyte antigen-DRB1 on the susceptibility to rheumatoid arthritis and on the production of anti-cyclic citrullinated peptide antibodies in a Portuguese population Ann Rheum Dis, February 1, 2007; 66(2): 246 - 248. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C Turesson, L T H Jacobsson, G Sturfelt, E L Matteson, L Mathsson, and J Ronnelid Rheumatoid factor and antibodies to cyclic citrullinated peptides are associated with severe extra-articular manifestations in rheumatoid arthritis Ann Rheum Dis, January 1, 2007; 66(1): 59 - 64. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kaltenhauser, M. Pierer, S. Arnold, M. Kamprad, C. Baerwald, H. Hantzschel, and U. Wagner Antibodies against cyclic citrullinated peptide are associated with the DRB1 shared epitope and predict joint erosion in rheumatoid arthritis Rheumatology, January 1, 2007; 46(1): 100 - 104. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K H Costenbader and E W Karlson Cigarette smoking and autoimmune disease: what can we learn from epidemiology? Lupus, November 1, 2006; 15(11): 737 - 745. [Abstract] [PDF]
|
|
|
|
|
|
D Makrygiannakis, E af Klint, I E Lundberg, R Lofberg, A-K Ulfgren, L Klareskog, and A I Catrina Citrullination is an inflammation-dependent process Ann Rheum Dis, September 1, 2006; 65(9): 1219 - 1222. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Ireland, J. Herzog, and E. R. Unanue Cutting Edge: Unique T Cells That Recognize Citrullinated Peptides Are a Feature of Protein Immunization J. Immunol., August 1, 2006; 177(3): 1421 - 1425. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E Berglin, T Johansson, U Sundin, E Jidell, G Wadell, G Hallmans, and S Rantapaa-Dahlqvist Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset Ann Rheum Dis, April 1, 2006; 65(4): 453 - 458. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. W. Zendman, W. J. van Venrooij, and G. J. M. Pruijn Use and significance of anti-CCP autoantibodies in rheumatoid arthritis Rheumatology, January 1, 2006; 45(1): 20 - 25. [Full Text] [PDF]
|
|
|
|
|
|
F. van Gaalen, A. Ioan-Facsinay, T. W. J. Huizinga, and R. E. M. Toes The Devil in the Details: The Emerging Role of Anticitrulline Autoimmunity in Rheumatoid Arthritis J. Immunol., November 1, 2005; 175(9): 5575 - 5580. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T Cantaert, P Coucke, L De Rycke, E M Veys, F De Keyser, and D Baeten Functional haplotypes of PADI4: relevance for rheumatoid arthritis specific synovial intracellular citrullinated proteins and anticitrullinated protein antibodies Ann Rheum Dis, September 1, 2005; 64(9): 1316 - 1320. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M M J Nielen, A R van der Horst, D van Schaardenburg, I E van der Horst-Bruinsma, R J van de Stadt, L Aarden, B A C Dijkmans, and D Hamann Antibodies to citrullinated human fibrinogen (ACF) have diagnostic and prognostic value in early arthritis Ann Rheum Dis, August 1, 2005; 64(8): 1199 - 1204. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Korendowych, P. Owen, J. Ravindran, C. Carmichael, and N. McHugh The clinical and genetic associations of anti-cyclic citrullinated peptide antibodies in psoriatic arthritis Rheumatology, August 1, 2005; 44(8): 1056 - 1060. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. J. Harney, C. Meisel, A.-M. Sims, P. Y. Woon, B. P. Wordsworth, and M. A. Brown Genetic and genomic studies of PADI4 in rheumatoid arthritis Rheumatology, July 1, 2005; 44(7): 869 - 872. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Samuels, Y.-S. Ng, C. Coupillaud, D. Paget, and E. Meffre Impaired early B cell tolerance in patients with rheumatoid arthritis J. Exp. Med., May 16, 2005; 201(10): 1659 - 1667. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Chapuy-Regaud, M. Sebbag, D. Baeten, C. Clavel, C. Foulquier, F. De Keyser, and G. Serre Fibrin Deimination in Synovial Tissue Is Not Specific for Rheumatoid Arthritis but Commonly Occurs during Synovitides J. Immunol., April 15, 2005; 174(8): 5057 - 5064. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L Caponi, E Petit-Teixeira, M Sebbag, F Bongiorni, S Moscato, F Pratesi, C Pierlot, J Osorio, S Chapuy-Regaud, M Guerrin, et al. A family based study shows no association between rheumatoid arthritis and the PADI4 gene in a white French population Ann Rheum Dis, April 1, 2005; 64(4): 587 - 593. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L De Rycke, X Verhelst, E Kruithof, F Van den Bosch, I E A Hoffman, E M Veys, and F De Keyser Rheumatoid factor, but not anti-cyclic citrullinated peptide antibodies, is modulated by infliximab treatment in rheumatoid arthritis Ann Rheum Dis, February 1, 2005; 64(2): 299 - 302. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J-E Gottenberg, S Mignot, P Nicaise-Rolland, J Cohen-Solal, F Aucouturier, J Goetz, C Labarre, O Meyer, J Sibilia, and X Mariette Prevalence of anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with primary Sjogren's syndrome Ann Rheum Dis, January 1, 2005; 64(1): 114 - 117. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L De Rycke, I Peene, I E A Hoffman, E Kruithof, A Union, L Meheus, K Lebeer, B Wyns, C Vincent, H Mielants, et al. Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestations Ann Rheum Dis, December 1, 2004; 63(12): 1587 - 1593. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
